Adrenergic alpha-1 Receptor Antagonists
"Adrenergic alpha-1 Receptor Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that bind to and block the activation of ADRENERGIC ALPHA-1 RECEPTORS.
| Descriptor ID |
D058668
|
| MeSH Number(s) |
D27.505.519.625.050.200.100.100 D27.505.696.577.050.200.100.100
|
| Concept/Terms |
Adrenergic alpha-1 Receptor Antagonists- Adrenergic alpha-1 Receptor Antagonists
- Adrenergic alpha 1 Receptor Antagonists
- Adrenergic alpha1-Antagonists
- Adrenergic alpha1 Antagonists
- alpha1-Antagonists, Adrenergic
- alpha-1 Adrenergic Blocking Agents
- alpha 1 Adrenergic Blocking Agents
- alpha1-Adrenoceptor Blocker
- alpha1 Adrenoceptor Blocker
- Adrenergic alpha-1 Antagonists
- Adrenergic alpha 1 Antagonists
- alpha-1 Antagonists, Adrenergic
- Adrenergic alpha-1 Receptor Blockers
- Adrenergic alpha 1 Receptor Blockers
|
Below are MeSH descriptors whose meaning is more general than "Adrenergic alpha-1 Receptor Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Adrenergic alpha-1 Receptor Antagonists".
This graph shows the total number of publications written about "Adrenergic alpha-1 Receptor Antagonists" by people in this website by year, and whether "Adrenergic alpha-1 Receptor Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2018 | 1 | 1 | 2 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Adrenergic alpha-1 Receptor Antagonists" by people in Profiles.
-
Covid-19 and development of heart failure: mystery and truth. Naunyn Schmiedebergs Arch Pharmacol. 2021 10; 394(10):2013-2021.
-
Doxazosin improved COVID-19 associated nightmare in a patient with major depressive disorder: a case report with a positive rechallenge. Int Clin Psychopharmacol. 2021 07 01; 36(4):221-223.
-
Alpha-1 adrenergic receptor antagonists to prevent hyperinflammation and death from lower respiratory tract infection. Elife. 2021 06 11; 10.
-
Association of a1-Blocker Receipt With 30-Day Mortality and Risk of Intensive Care Unit Admission Among Adults Hospitalized With Influenza or Pneumonia in Denmark. JAMA Netw Open. 2021 02 01; 4(2):e2037053.
-
Preventing cytokine storm syndrome in COVID-19 using a-1 adrenergic receptor antagonists. J Clin Invest. 2020 07 01; 130(7):3345-3347.
-
The Man Who Saw Things on Carvedilol. Tokai J Exp Clin Med. 2019 Jul 20; 44(2):29-30.
-
Effects of CYP2D6 and CYP3A5 genetic polymorphisms on steady-state pharmacokinetics and hemodynamic effects of tamsulosin in humans. Eur J Clin Pharmacol. 2018 Oct; 74(10):1281-1289.
-
The relevance of drug-drug interactions in clinical practice: the case of concomitant boosted protease inhibitors plus alpha-1 blocker administration. Antivir Ther. 2018; 23(5):467-469.